Effect of norethindrone acetate in the treatment of symptomatic endometriosis
Other
OA: closed
CC0
⤵ 56 in-corpus citations
AI-generated summary
Norethindrone acetate relieved dysmenorrhea, noncyclic pelvic pain, and overall pain in most women with symptomatic endometriosis, despite breakthrough bleeding being a common side effect.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: The purpose of the study was to evaluate the efficacy of norethindrone acetate (NA) treatment in 52 women with dysmenorrhea, dyspareunia, noncyclic pelvic pain who had a diagnosis of endometriosis by laparoscopy.
RESULTS: Dysmenorrhea and noncyclic pelvic pain were relieved in 48/52 (92.3%) and 25/28 (89.2%) of patients, respectively. Overall pain relief was obtained in 49/52 (94.2%) of patients. Breakthrough bleeding, of variable severity, was the most common side effect experienced by 30 patients (57.6%); however, only 4 patients (7.7%) dropped out for this side effect. One other patient dropped out for severe breast tenderness, and three for noncyclic pelvic pain. In general, treatment was successful in 44/52 (84.5%) of patients with the above symptoms.
CONCLUSION: NA seems to be a cost-effective alternative with relatively mild side effects in the treatment of symptomatic endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (50)
- Optimize your treatment of endometriosis by using an FDA-approved hormonal medication 2021
- Medical management of endometriosis 2021
- Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence 2021
- Endometriosis Treatment 2020
- Endometriosis 2019
- Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? 2019
- [Not Available] 2019
- Future Directions in Endometriosis Research and Therapeutics 2018
- Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study 2018
- Shifting from Oral Contraceptives to Norethisterone Acetate, or Vice Versa, because of Drug Intolerance: Does the Change Benefit Women with Endometriosis? 2018
- Medical treatment of endometriosis-related pain 2018
- Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain? 2018
- A stepped-care approach to symptomatic endometriosis management: a participatory research initiative 2018
- Oral and depot progestin therapy for endometriosis: towards a personalized medicine 2017
- Efficacy of Norethisterone in Patients with Ovarian Endometrioma 2017
- Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills 2017
- Women with inherited bleeding disorders and their offspring - the unresolved issues 2017
- Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis 2017
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
- Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 2016
- Pharmacologic treatment of the ovarian endometrioma 2016
- Progestogens and Endometriosis 2015
- Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study 2015
- Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age 2014
- New trends of progestins treatment of endometriosis 2014
- Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment 2014
- Medical treatments for endometriosis-associated pelvic pain 2014
- Medikamentöse Therapie der Endometriose 2013
- Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life 2013
- Norethindrone acetate in the medical management of adenomyosis 2012
- Medical management of recurrent endometrioma with long-term norethindrone acetate 2012
- Management of chronic pelvic pain 2011
- Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms 2011
- Brief update on endometriosis treatment 2011
- Medical Therapies: Progestins 2011
- Innovations in conservative endometriosis treatment: an updated review 2011
- Endometrioza w wieku przed- i oko³omenopauzalnym - jak leczyæ? Endometriosis in pre- and perimenopausal age - how to treat? 2011
- Endometriosis in pre- and perimenopausal age – how to treat? 2011
- Dienogest in long-term treatment of endometriosis 2011
- Current pharmacotherapy for endometriosis 2010
- Medical Management of Pain Associated With Endometriosis 2010
- Dienogest: an oral progestogen for the treatment of endometriosis 2010
- [Current aspects on diagnosis and treatment of endometriosis] 2010
- Membranous dysmenorrhea: a complication of treatment for endometriosis 2010
- Endometriosis: current therapies and new pharmacological developments 2009
- Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study 2009
- Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging 2007
- The role of progestins in treating the pain of endometriosis 2006
- Medical management of endometriosis 2006
- Tratamento da endometriose 2006
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T22:00:35.617750+00:00
License: CC0
· commercial use OK